Sesen Bio Inc. [NASDAQ: SESN] loss -1.18% or -0.05 points to close at $4.20 with a heavy trading volume of 4444547 shares. The company report on June 2, 2021 that Sesen Bio Announces Global Supply Partnership with Qilu Pharmaceutical.
Technology transfer to Qilu Pharmaceutical on track for completion in 2021.
Sesen Bio to receive $2M milestone payment upon completion of technology transfer.
It opened the trading session at $4.29, the shares rose to $4.29 and dropped to $4.055, the range by which the price of stock traded the whole day. The daily chart for SESN points out that the company has recorded 151.50% gains over the past six months. However, it is still -536.36% lower than its most recent low trading price.
If we look at the average trading volume of 5.76M shares, SESN reached to a volume of 4444547 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here is what top equities market gurus are saying about Sesen Bio Inc. [SESN]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for SESN shares is $7.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on SESN stock is a recommendation set at 1.30. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
H.C. Wainwright have made an estimate for Sesen Bio Inc. shares, keeping their opinion on the stock as Buy, with their previous recommendation back on June 11, 2019.
The Average True Range (ATR) for Sesen Bio Inc. is set at 0.25, with the Price to Sales ratio for SESN stock in the period of the last 12 months amounting to 46.18. The Price to Book ratio for the last quarter was 70.00, with the Price to Cash per share for the same quarter was set at 0.65.
Trading performance analysis for SESN stock
Sesen Bio Inc. [SESN] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 1.69. With this latest performance, SESN shares gained by 79.49% in over the last four-week period, additionally plugging by 151.50% over the last 6 months – not to mention a rise of 459.55% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for SESN stock in for the last two-week period is set at 76.50, with the RSI for the last a single of trading hit 80.07, and the three-weeks RSI is set at 72.55 for Sesen Bio Inc. [SESN]. The present Moving Average for the last 50 days of trading for this stock 2.95, while it was recorded at 4.21 for the last single week of trading, and 2.02 for the last 200 days.
Sesen Bio Inc. [SESN]: A deeper dive into fundamental analysis
Operating Margin for any stock indicates how profitable investing would be, and Sesen Bio Inc. [SESN] shares currently have an operating margin of -287.09. Sesen Bio Inc.’s Net Margin is presently recorded at -199.33.
Reflecting on the efficiency of the workforce at the company, Sesen Bio Inc. [SESN] managed to generate an average of -$829,519 per employee.Sesen Bio Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 7.30 and a Current Ratio set at 7.30.
Sesen Bio Inc. [SESN]: An earnings per share (EPS) analysis
With the latest financial reports released by the company, Sesen Bio Inc. posted -0.24/share EPS, while the average EPS was predicted by analysts to be reported at -0.09/share. When compared, the two values demonstrate that the company fail the estimates by a Surprise Factor of -166.70%. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for SESN.
An analysis of insider ownership at Sesen Bio Inc. [SESN]
There are presently around $169 million, or 23.50% of SESN stock, in the hands of institutional investors. The top three institutional holders of SESN stocks are: VANGUARD GROUP INC with ownership of 7,195,552, which is approximately 22.091% of the company’s market cap and around 0.02% of the total institutional ownership; TRV GP, LLC, holding 4,091,591 shares of the stock with an approximate value of $17.18 million in SESN stocks shares; and RENAISSANCE TECHNOLOGIES LLC, currently with $15.74 million in SESN stock with ownership of nearly 28.749% of the company’s market capitalization.
Positions in Sesen Bio Inc. stocks held by institutional investors increased at the end of May and at the time of the May reporting period, where 59 institutional holders increased their position in Sesen Bio Inc. [NASDAQ:SESN] by around 17,486,692 shares. Additionally, 16 investors decreased positions by around 5,014,701 shares, while 6 investors held positions by with 17,635,814 shares. The mentioned changes placed institutional holdings at 40,137,207 shares, according to the latest SEC report filing. SESN stock had 24 new institutional investments in for a total of 2,017,895 shares, while 5 institutional investors sold positions of 1,682,915 shares during the same period.